Novo Nordisk to Lay off 400 to Focus on Innovation
Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.
The Home of the Life Sciences Industry
Explore Latest News
Allergan and Sosei Halt Alzheimer’s Trial Over Safety Concerns
Allergan and its development partner Sosei Group have voluntarily suspended clinical trials of HTL0018318 in Alzheimer’s and other types of dementia because of safety problems.
- House Rejects Senate Bill Provision to Require Disclosure of Drug Prices in Television Commercials
- Novartis Ties Ethics Scoring System With Annual Bonuses
- Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling
- More Changes to the Pharmacy Industry Coming as DOJ Approves Cigna-Express Scripts Deal
- 5 Reasons Why Most People Aren’t Happy at Work
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.